204 related articles for article (PubMed ID: 1341444)
1. Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2b.
Fuchs D; Norkrans G; Wejstal R; Reibnegger G; Weiss G; Weiland O; Schvarcz R; Fryden A; Wachter H
Eur J Med; 1992; 1(4):196-200. PubMed ID: 1341444
[TBL] [Abstract][Full Text] [Related]
2. Enhanced serum levels of beta-2-microglobulin, neopterin, and interferon-gamma in patients treated with recombinant tumor necrosis factor-alpha.
Aulitzky WE; Tilg H; Herold M; Berger M; Vogel W; Judmaier G; Gastl G; Mull B; Flener R; Wiegele J
J Interferon Res; 1988 Oct; 8(5):655-64. PubMed ID: 3148671
[TBL] [Abstract][Full Text] [Related]
3. Serum and urinary neopterin levels in patients with chronic active hepatitis B treated with interferon.
Daito K; Suou T; Kawasaki H
Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):303-16. PubMed ID: 8008980
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantation.
Tilg H; Vogel W; Aulitzky WE; Herold M; Königsrainer A; Margreiter R; Huber C
Transplantation; 1990 Jun; 49(6):1074-80. PubMed ID: 2163132
[TBL] [Abstract][Full Text] [Related]
5. Pilot study of natural human interleukin-2 in patients with chronic hepatitis B. Immunomodulatory and antiviral effects.
Tilg H; Vogel W; Tratkiewicz J; Aulitzky WE; Herold M; Gruber M; Geissler D; Umlauft F; Judmaier G; Schwulera U
J Hepatol; 1993 Sep; 19(2):259-67. PubMed ID: 8301059
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha-induced biologic modifications in patients with chronic myelogenous leukemia.
Liberati AM; Horisberger MA; Garofani P; De Angelis V; Ferrajoli A; Di Clemente F; Caricchi P; Adiuto D; Fedeli L; Palumbo B
J Interferon Res; 1994 Dec; 14(6):349-55. PubMed ID: 7897254
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha.
Quiroga JA; Martin J; Pardo M; Carreño V
Dig Dis Sci; 1994 Nov; 39(11):2485-96. PubMed ID: 7956620
[TBL] [Abstract][Full Text] [Related]
8. Serum lipid levels during interferon therapy in patients with chronic hepatitis C.
Picciotto A; Bertolini S; Bardellini E; Borro P; Borzone S; Masturzo P; Pireddu M; Sinelli N; Celle G
J Interferon Cytokine Res; 1995 Aug; 15(8):703-4. PubMed ID: 8528942
[TBL] [Abstract][Full Text] [Related]
9. Prolonged interferon-gamma application by subcutaneous infusion in cancer patients: differential response of serum CD14, neopterin, and monocyte HLA class I and II antigens.
Landmann R; Ludwig C; Wesp M; Fisscher A; Obrist R; Knüsli C; Denz H; Obrecht JP
J Interferon Res; 1992 Apr; 12(2):103-11. PubMed ID: 1374454
[TBL] [Abstract][Full Text] [Related]
10. Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.
Schiller JH; Storer B; Witt PL; Nelson B; Brown RR; Horisberger M; Grossberg S; Borden EC
Cancer Res; 1990 Aug; 50(15):4588-94. PubMed ID: 2114942
[TBL] [Abstract][Full Text] [Related]
11. [Changes in serum levels of beta 2-microglobulin, neopterin and 2',5'-oligoadenylate synthase activity during clearance of hepatitis B virus with or without acute phase in transaminases].
Carreño García V; Hernández-Guío C; Bartolomé Nebreda J; Quiroga Estévez JA
Rev Esp Enferm Dig; 1993 Mar; 83(3):169-75. PubMed ID: 7683894
[TBL] [Abstract][Full Text] [Related]
12. Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha.
Hofmann B; Bass H; Nishanian P; Faisal M; Figlin RA; Sarna GP; Fahey JL
Clin Exp Immunol; 1992 Jun; 88(3):548-54. PubMed ID: 1606739
[TBL] [Abstract][Full Text] [Related]
13. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection.
Fuchs D; Möller AA; Reibnegger G; Werner ER; Werner-Felmayer G; Dierich MP; Wachter H
Immunol Lett; 1991 Jun; 28(3):207-11. PubMed ID: 1909303
[TBL] [Abstract][Full Text] [Related]
14. Association between neopterin and beta-2-microglobulin levels and HIV status in Romanian orphanage children.
Zaknun D; DiFranco M; Oswald HP; Zaknun J; Mayersbach P; Vuja E; Wachter H; Fuchs D
Wien Klin Wochenschr; 1993; 105(10):284-8. PubMed ID: 8517058
[TBL] [Abstract][Full Text] [Related]
15. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
Schiller JH; Storer B; Paulnock DM; Brown RR; Datta SP; Witt PL; Borden EC
J Clin Invest; 1990 Oct; 86(4):1211-21. PubMed ID: 2120284
[TBL] [Abstract][Full Text] [Related]
16. Tolerability of interferon alpha-2b, a possible new treatment of active Crohn's disease.
Davidsen B; Munkholm P; Schlichting P; Nielsen OH; Krarup H; Bonnevie-Nielsen V
Aliment Pharmacol Ther; 1995 Feb; 9(1):75-9. PubMed ID: 7766748
[TBL] [Abstract][Full Text] [Related]
17. Patterns of serological markers for cellular immune activation in patients with dilated cardiomyopathy and chronic myocarditis.
Samsonov M; Fuchs D; Reibnegger G; Belenkov JN; Nassonov EL; Wachter H
Clin Chem; 1992 May; 38(5):678-80. PubMed ID: 1582019
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha.
Grüngreiff K; Reinhold D; Ansorge S
Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433
[TBL] [Abstract][Full Text] [Related]
19. Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS.
Krown SE; Niedzwiecki D; Bhalla RB; Flomenberg N; Bundow D; Chapman D
J Acquir Immune Defic Syndr (1988); 1991; 4(9):871-80. PubMed ID: 1895208
[TBL] [Abstract][Full Text] [Related]
20. Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages.
Niederwieser D; Herold M; Woloszczuk W; Aulitzky W; Meister B; Tilg H; Gastl G; Bowden R; Huber C
Transplantation; 1990 Oct; 50(4):620-5. PubMed ID: 2171163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]